Photocure ASA: Annual accounts 2017

Oslo, 16 April 2018: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2017.

The annual accounts and annual report for the financial year 2017 are enclosed with this notification and made available on the company‘s website, . ┬á

For further information, please :

Photocure
CFO Erik Dahl
Tel: +47 450 55 000, ed.no

About Photocure ASA
Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at www.photocure, www.hexvix, .

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachment

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.